Brief Report: Challenges in Obtaining the Informed Perspectives of Stakeholders Regarding HIV Molecular Epidemiology
- PMID: 36805407
- PMCID: PMC10293093
- DOI: 10.1097/QAI.0000000000003179
Brief Report: Challenges in Obtaining the Informed Perspectives of Stakeholders Regarding HIV Molecular Epidemiology
Abstract
Background: HIV molecular epidemiology (HIV-ME) is now being used in a variety of ways, including molecular HIV surveillance to help identify and respond to emerging HIV transmission clusters as specified in the Ending the HIV Epidemic in the U.S. initiative. However, HIV-ME in general, and its use for cluster detection and response, in particular, raises significant ethical and social concerns, which have spurred vigorous debates. Nevertheless, there is a paucity of information regarding how these potential benefits and concerns are perceived among people living with HIV and people without HIV at an increased risk.
Setting: Virtual engagement with US participants.
Methods: We rigorously developed a brief informational video about HIV-ME and conducted a series of in-depth interviews with people living with HIV and people without HIV at an increased risk.
Results: Through extensive stakeholder engagement during the video development process and subsequent in-depth interviews (N = 24), several preliminary findings surfaced. In contrast to the high level of concern raised by some critics of HIV-ME, our data appear to show broad support for it. In addition, we observed conflation of perspectives about HIV-ME with concerns about HIV public health surveillance more generally.
Conclusion: Our experiences reveal substantial communication challenges related to the nature of HIV-ME that need to be overcome to ensure that it is properly understood, which is necessary for meaningfully engaging stakeholders in discussions about its use. Moreover, ongoing, responsive, engagement efforts are critical. Additional systematic data are needed to help inform policy making and practice regarding HIV-ME.
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
Conflicts of Interest: Jeremy Sugarman is a member of Merck KGaA’s Ethics Advisory Panel and Stem Cell Research Oversight Committee; a member of IQVIA’s Ethics Advisory Panel; a member of Aspen Neurosciences Clinical Advisory Panel; a member of a Merck Data Monitoring Committee; and a consultant to Biogen. None of these activities are related to the material discussed in this manuscript. The other authors have no disclosures.
References
-
- Fauci AS, Redfield RR, Sigounas G, et al. Ending the HIV Epidemic. JAMA. 2019;321(9):844. - PubMed
-
- Centers for Disease Control and Prevention. HIV cluster and outbreak detection and response; 2022. [cited 2022 August 24] Available from: https://www.cdc.gov/hiv/programresources/guidance/cluster-outbreak/index....
-
- Molldrem S, Smith AKJ. Reassessing the Ethics of Molecular HIV Surveillance in the Era of Cluster Detection and Response: Toward HIV Data Justice. Am J Bioeth. 2020;20(10):10–23. - PubMed
-
- Whitehead S Critics Worry Government Surveillance of HIV May Hurt More Than It Helps. Kaiser Health News; 2022.[cited 2022 September 20]. Available from: https://khn.org/news/article/government-surveillance-hiv-criminalization....
-
- Bernard EJ, McClelland A, Cardell B, et al. We Are People, Not Clusters! The American Journal of Bioethics. 2020;20(10):1–4. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical